Deadly Disease Detected at Grand Canyon
Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content.
A park employee at Grand Canyon National Park in Arizona was confirmed to have been exposed to hantavirus, which is rare but often fatal, Coconino County health officials confirmed after the July 4 holiday weekend, according to local news outlet 8newsnow.com.
Officials also confirmed a separate case of rabies exposure at the park.
Newsweek has contacted the National Park Service, Coconino County Health and Human Services and the Arizona Department of Health Services outside of regular working hours via email for comment.
Left, a generic image shows a deer mouse, and, right, a view of the Grand Canyon.
Left, a generic image shows a deer mouse, and, right, a view of the Grand Canyon.
Karel Bock left) and Richey Miller right)/Getty Images (left and Cal Sport Media via AP (right
Why It Matters
Hantavirus is primarily spread by deer mice, which are prevalent in the Grand Canyon area. The virus can cause a host of serious, even fatal, illnesses such as hantavirus pulmonary syndrome (HPS) and hemorrhagic fever with renal syndrome (HFRS), according to the Centers for Disease Control and Prevention (CDC).
The CDC said that HPS has a 38 percent fatality rate, while fatality rates for HFRS depend on the virus strain. New Mexico, Arizona, Colorado and California record the highest number of hantavirus infections nationally, although the virus remains rare.
This is not the first time the virus has been traced to a National Park—for example, there were also cases of HPS in visitors to Yosemite National Park in 2012.
What To Know
The virus is typically transmitted from rodent to human, and not human-to-human, usually following exposure to rat or mice urine, droppings or saliva. It can also spread via a bite or scratch, but this is unlikely.
Those who handle and clean up after rodents, such National Park employees, are at higher risk of hantavirus exposure and should take precautions, the CDC advises.
Authorities did not state how the Grand Canyon employee was thought to have been exposed to the virus.
Grand Canyon spokesperson Joelle Baird told the San Francisco news outlet SFGATE that park service is going to "incredible lengths for cleanup" to control the spread of the virus.
The spokesperson informed the outlet that on June 20, the employee began to experience symptoms of HPS and went to Flagstaff Medical Center, where they received treatment.
They have since been released from the hospital and continue to recover but the spokesperson was uncertain of when the employee would return to work, SFGATE reported.
Five cases of hantavirus have been reported in Arizona so far this year, according to local news outlet 8newsnow.com, citing state officials.
Hantavirus hit the headlines earlier this year when an autopsy confirmed that the late actor Gene Hackman's wife, Betsy Arakawa, died from HPS in Santa Fe, New Mexico.
The Grand Canyon National Park has also confirmed a rabies case, which it linked to a bat collected near Kanab Creek Canyon, according to the local news outlet Austin American Stateman.
Health officials reported the bat tested positive for rabies. Two people who had physical contact with the animal received medical evaluation and treatment, according to a statement from the Grand Canyon National Park.
What People Are Saying
The CDC says on its website: "People should avoid contact with rodent urine, droppings, saliva, and nesting materials. If mice or rats are in or around your home, it's important to clean up after them safely. Rodent control is the primary strategy for preventing hantavirus pulmonary syndrome (HPS), a disease caused by infection with certain hantaviruses. Wild rodents near human populations should be controlled and excluded from homes."
The Nevada Office of State Epidemiology says on its website: "In the U.S., deer mice, cotton rats, rice rats, and the white-footed mouse can carry the hantavirus disease. These rodents spread the virus in their urine, droppings, and saliva. People mainly get the virus from breathing in contaminated air such as when cleaning sheds, barns, or garages where infected rodents are found."
What Happens Next
Public health authorities in Arizona are actively monitoring rodent populations and potential hantavirus cases, and the Grand Canyon National Park continues to adhere to a number of protocols regarding hantavirus safety.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Fox News
an hour ago
- Fox News
Doctors reveal key signs of Lyme disease as tick season intensifies across US
Lyme disease is prevalent this time of year, especially in the Northeast, mid-Atlantic and upper-Midwest regions of the U.S. — though there have been reports of cases in expanding areas, according to the Centers for Disease Control and Prevention (CDC). Borrelia burgdorferi, the bacterial infection that causes Lyme disease, is transmitted to humans through the bite of a black-legged (deer) tick, per the above source. Deer ticks the size of a poppy seed can inject a numbing chemical when they bite, allowing the infection to go undetected until symptoms begin to show weeks later. The infection can lead to severe muscle and joint pain, Lyme arthritis, cardiac complications and neurological conditions, experts told Fox News Digital. A telltale sign of Lyme disease is a red circular bull's-eye rash or multiple rashes on the skin, especially in tick-endemic regions. Between 60% and 80% of patients will develop a rash, according to experts. "We're looking for specific findings, like the classic bull's-eye rash, a swollen joint or a facial droop called Bell's palsy, which can be seen with Lyme disease," Dr. Andrew Handel, a pediatric infectious disease specialist at Stony Brook Children's Hospital on Long Island, New York, said in an interview with Fox News Digital. Symptoms typically emerge two weeks after the bite, becoming more severe if they go untreated. If the infection isn't treated at the time of the rash, patients will typically seek medical attention for later manifestations of the infection, Handel noted. Those can include Bell's palsy (facial nerve paralysis), Lyme meningitis (often marked by severe headache, neck stiffness and fever) and carditis (inflammation of heart tissues). One of the earliest signs of Lyme disease is overwhelming fatigue and joint aches, according to Dr. Daniel Cameron, an epidemiologist in Mount Kisco, New York, who specializes in tick-borne illnesses. Other symptoms may include fever, brain fog, dizziness, palpitations and nerve pain, among others. A blood test can help diagnose Lyme disease, but timing matters. "The way we diagnose Lyme disease in the blood is by looking for antibodies, for the immune system's response to the infection, as opposed to other infectious testing, where you find the bacteria itself," Handel told Fox News Digital. Testing too early can result in a false negative, as antibody tests often don't turn positive until three or four weeks after the tick bite occurred. After sustaining a tick bite, experts recommend immediately removing the tick and seeing a healthcare provider. Doctors will typically prescribe a post-exposure prophylaxis (PEP) with a 200-milligram dose of the antibiotic doxycycline to be taken within 72 hours of a high-risk tick bite, epidemiologists told Fox News Digital. "It's the immune system's lingering response to the infection that you had in the past." Although studies have found this dose to be effective in the majority of cases, some physicians prefer a longer course of treatment for tick bites. "I'm not a big fan of a single dose of doxycycline [200 mg] for a tick bite, even though it's pretty popular," Cameron told Fox News Digital. "I don't feel comfortable with a single dose if I really want to avoid Lyme." Instead, Cameron prefers a four-week course of antibiotics for suspected Lyme disease cases. For patients who don't want to take antibiotics right away, he said he will "watch and wait" to see if symptoms emerge and then treat accordingly. The doctor recommends that patients follow up in a month to be assessed and undergo screenings for other infections if necessary. In the event that a patient develops Lyme, the disease typically responds well to a course of antibiotics, which may include doxycycline, amoxicillin or cefuroxime, according to experts. Treatment duration can vary from 10 days up to four to six weeks. Chronic Lyme disease — also known as post-treatment Lyme disease syndrome (PTLDS) — is a condition that affects a subgroup of patients who were already treated for Lyme disease, but continue to have symptoms. "The bacteria is dead and gone. It's the immune system's lingering response to the infection that you had in the past," Handel told Fox News Digital. For these cases, doctors typically prescribe symptom-based therapies rather than additional antibiotics. More research is needed in the field of PTLDS, experts agree. "It remains an area that requires further understanding and investigation as to how to optimally treat the symptoms that patients have," Dr. Aaron Glatt, a hospital epidemiologist at Mount Sinai South Nassau on Long Island, New York, and spokesperson for the Infectious Diseases Society of America, said in an interview with Fox News Digital. "However, the current data do not support providing additional antibiotic therapy for this condition." If someone suspects they have PTLDS, they should discuss with their physician the possibility of other diseases, such as babesiosis, which is widely regarded as the second-most common tick-borne illness in the Northeastern U.S. While babesiosis is spread by the same tick as Lyme disease, it is caused by a parasite called Babesia microti rather than a bacterium, per the CDC. "It's the same tick, but doxycycline doesn't do a thing for it, whether you take two pills or the full course," Cameron said. "You'll never get control of Babesia until you take some anti-parasite medicine." If someone does not respond to Lyme treatment, Cameron recommends that they get tested for babesiosis and receive antiparasitic medications if necessary. The best way to prevent Lyme disease is to avoid tick bites in the first place, experts agree. They recommend taking the following preventive measures. For more Health articles, visit If you do find a tick on your body, Cameron and Handel suggest following the protocol below.
Washington Post
an hour ago
- Washington Post
Senate to vote on Trump's pick to lead the CDC
The Senate is scheduled to vote Tuesday on confirming longtime federal government scientist Susan Monarez to lead the Centers for Disease Control and Prevention, the public health agency that is under intense scrutiny as Robert F. Kennedy Jr. upends vaccine policy in the United States. Monarez, President Donald Trump's second pick for the job, is expected to be confirmed because Republicans who control the chamber have not expressed opposition to her nomination.
Newsweek
2 hours ago
- Newsweek
America's Obesity Epidemic Is Finally Easing. Will MAHA Take Credit?
Based on facts, either observed and verified firsthand by the reporter, or reported and verified from knowledgeable sources. Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content. When the Make America Healthy Again (MAHA) initiative launched in early 2025, Health and Human Services Secretary Robert F. Kennedy Jr. framed it as nothing short of a national reset. School meal reforms, bans on artificial dyes and restrictions on sugary drink purchases under SNAP were promoted as the first steps in addressing what Kennedy called a "childhood chronic disease crisis." The administration projected measurable progress within two years: a nation reversing decades of rising obesity. But the first signs of change had already appeared. In 2023, national data showed adult obesity plateauing for the first time in more than a decade. An analysis of 16.7 million health records found the average U.S. body mass index (BMI) dipping slightly from 30.24 to 30.21, while the unweighted obesity rate fell from 46.0 percent to 45.6 percent. Researchers credited one factor: a surge in prescriptions for GLP‑1 weight-loss drugs like Ozempic and Wegovy. That timeline sets up a political and scientific tension, according to experts consulted by Newsweek. If obesity rates keep dropping into 2026 and beyond, MAHA's policy agenda could be positioned to claim credit for a trend largely driven by pharmaceutical breakthroughs that predate it. Photo-illustration by Newsweek/Getty/Canva/ChatGPT 'Good Intentions' "The intention of what RFK Jr. wants in this area is good," said Dr. Robert Klitzman, professor of psychiatry and director of the bioethics program at Columbia University. "In terms of improving Americans' diets and fighting chronic disease, his stated intentions are good. But I'm not convinced the administration will act effectively on those intentions." Klitzman pointed to contradictions between MAHA's public messaging and broader Trump administration policy. While MAHA emphasizes banning dyes, swapping out cane sugar for high-fructose corn syrup and cutting sugary drinks from public programs, the administration has simultaneously cut federal nutrition research, reduced SNAP benefits and eliminated CDC environmental health programs. "The president's proposed Fiscal Year 2026 budget would cut more than $18 billion in NIH research funding, 40 percent of the budget," the Center for Science in the Public Interest (CSPI) warned in a June 2025 report. "In addition, the Division of Environmental Health Science and Practice at the CDC was eliminated as part of a widespread reduction in force of 10,000 employees across HHS." "Good intentions are not enough," Klitzman said. "The real impact on public health remains unclear." Kennedy's high-profile food policy moves—such as urging Coca-Cola to switch back to cane sugar—illustrate the risk. "If people think, 'Oh, we got rid of the food dyes, now junk food is healthy,' they may actually consume more unhealthy food," Klitzman said. "Replacing high-fructose corn syrup with cane sugar doesn't make a product healthier if the calorie count is the same." Research backs this up: FDA and JAMA studies show cane sugar and HFCS have nearly identical metabolic effects when consumed in similar amounts. A 2022 meta-analysis found no significant difference in weight or blood markers between the two. A stock image shows a person holding Ozempic Insulin injection pens for diabetes/ weight loss. A stock image shows a person holding Ozempic Insulin injection pens for diabetes/ weight loss. getty images The GLP‑1 Surge Experts widely agree that the modest nationwide weight-loss trend so far stems from the pharmacological innovation of GLP‑1 drugs, not health policy. Prescriptions for medications like Ozempic rose nearly 600 percent between 2019 and 2024, with roughly 4 percent of U.S. adults using them as of last year, according to FAIR Health/IQVIA data. "GLP‑1s are already showing real results," said Dr. Raj Dasgupta, chief medical advisor at Garage Gym Reviews. "Banning additives or restricting sugary drinks sends a message, sure, but on their own they're unlikely to move the needle in a big way." For dietitians like Dasgupta, GLP‑1 medications delivered what the U.S. had lacked for decades: a treatment that not only helped patients lose weight but also improved key health markers. Clinical trials show users can lose 15 to 25 percent of their body weight while also improving blood sugar control, lowering blood pressure and boosting cardiovascular health. Robert F. Kennedy Jr., Secretary of the Department of Health and Human Services, testifies before the Senate Committee on Health, Education, Labor, and Pensions, Washington DC, May 14, 2025. Robert F. Kennedy Jr., Secretary of the Department of Health and Human Services, testifies before the Senate Committee on Health, Education, Labor, and Pensions, Washington DC, May 14, 2025. Aaron Schwartz/Sipa via AP Images Yet the surge of Ozempic, Mounjaro, and Wegovy has reframed weight loss as a medical intervention—but one largely limited to those who can afford it. Users often regain weight once they stop treatment, and with prices ranging from $1,000 to $1,400 a month and patchy insurance coverage, access remains out of reach for many. In a country where 42 percent of adults live with obesity—a rate that has nearly doubled since the 1980s—the arrival of a drug that actually works is hard to ignore. But Dasgupta warned of a policy risk if future improvements are credited to MAHA's incremental measures. "If obesity rates drop because of GLP‑1 use, but we claim it's because of soda taxes or additive bans, we double down on the wrong things. That kind of misalignment can set us back." Aviva Musicus, science director at the Center for Science in the Public Interest, told Newsweek the pattern is already emerging. "RFK Jr. recently posted that 'MAHA is winning' in response to a fast-food chain switching to cane sugar in sodas," she said. Studies consistently show sugar-sweetened beverages are linked to higher risks of obesity, type 2 diabetes, and cardiovascular disease, regardless of the sweetener source, according to the CDC. "Sugary drinks are one of the most harmful products in our food supply. To actually improve health, the administration should focus on less sugar, not different sugar," Musicus added. MAHA's emphasis on prevention has merit, experts say, but its impact will take years to measure. "Prevention takes time—15 to 20 years to see real results," Dr. John Magaña Morton, professor of bariatric surgery at Yale, told Newsweek. "In the meantime, what do we do for patients suffering now? That's where treatment comes in. You need both prevention and treatment. It's like love and marriage—you can't have one without the other." Morton noted that severe obesity (defined as a BMI over 40) continues to rise even as overall rates plateau. "The new drugs are paradigm-shifting, but about 20 percent of patients can't tolerate them or don't see results," he said. "Not everyone wants surgery either. We need metabolic centers to figure out who's most at risk and what other approaches work." A stock image of an obese man seated in a crowd outdoors, August 26, 2016. Obesity rates vary significantly across the U.S., with the highest rates in the Midwest and South. A stock image of an obese man seated in a crowd outdoors, August 26, 2016. Obesity rates vary significantly across the U.S., with the highest rates in the Midwest and South. Richard T. Nowitz/Getty Images Setting Up a Future Claim To be sure, Kennedy hasn't explicitly claimed credit for the national weight-loss trend. But MAHA's framing—that its policies will "end the chronic disease epidemic" within years—positions the initiative to take a victory lap if obesity rates decline during its tenure. That's exactly what worries experts. "It's very risky," Klitzman said. "If we credit the wrong things, we risk building future policy on shaky ground. We can't afford to misread what's actually helping people." Musicus shared the same concern. "So far, we haven't seen MAHA use policy to drive real improvements in the food system. Instead, it's leaned on voluntary industry commitments that have failed before," she said. Many of MAHA's pledges—like altering soda recipes—aren't enforceable regulations and historically have had little measurable impact. "If they start taking credit for GLP‑1-driven declines without making structural changes, we risk losing the chance to create lasting, meaningful improvements." CSPI also questioned the administration's approach. "Even when the report outlines a good idea—like increasing consumption of whole, unprocessed foods—the administration's actions since January are at odds with these ideas," the group noted. "Back in March, the administration terminated more than $1 billion in funding that helped small farmers put fresh, local food into schools and food banks." For Morton, the solution lies in balance. "Obesity is a health tax on everything," he said. "We are finally paying attention, which is good. But this is going to require a multi-pronged approach, not a single narrative about who gets the credit." With the MAHA Commission set to release its next policy recommendations in August, the stakes are high: the story America tells itself about reversing obesity could shape public health strategy for decades. A March 2025 JAMA Health Forum article raised similar concerns. "The MAHA commission's priorities depart from the known causes of chronic diseases," it said. "There is no mention of added sugars in food, reducing sodium intake, or the use of alcohol or tobacco. Instead, the charge includes issues that contribute in limited ways, rest on shaky evidence, or reflect the Secretary's long-held views."
